Get started

Press Releases

Delayed 3m

Fastest customizable press release feed in the world.

Signed out · Sign up for real-time

Updates arrive automatically.

  • Community Meeting Answers Questions for More Than 100 Participants as They Prepare to Submit Claims to SCE’s Wildfire Recovery Compensation Program
    PR·

    Community Meeting Answers Questions for More Than 100 Participants as They Prepare to Submit Claims to SCE’s Wildfire Recovery Compensation Program

    Nov. 12 in-person session in Pasadena provides another opportunity to learn more ahead of Nov. 30 submission deadline, with more than 17,600 participants already submitting claims. With the Nov. 30 deadline approaching to submit a claim to Southern California Edison’s Wildfire Recovery Compensation Program, SCE is continuing to provide opportunities for community members impacted by the Eaton Fire to learn about the program, ask questions and get help submitting a claim. More than 100 participants attended last week’s virtual community meeting. An in-person meeting on Thurs., Nov. 12 in Pasadena will provide another opportunity for community members to get their questions answered and c

    $EIX
  • Align Technology Recognized in Extel’s 2026 All-America Executive Team Rankings
    PR·

    Align Technology Recognized in Extel’s 2026 All-America Executive Team Rankings

    Align recognized for executive leadership, investor relations and investor engagement in the Health Care Technology & Distribution sector The 2026 awards mark Align’s fourth recognition in five years in the Extel All-America Executive Team rankings Align Technology, Inc. ("Align") (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced recognition in the 2026 All-America Executive Team rankings published by Extel Insights (formerly Institutional Investor Research), which evaluates the qu

    $ALGN
  • Heartland Express to Ring Nasdaq Closing Bell to Commemorate 48 Years in Transportation and 40 Years as a Publicly Traded Company
    PR·

    Heartland Express to Ring Nasdaq Closing Bell to Commemorate 48 Years in Transportation and 40 Years as a Publicly Traded Company

    Heartland Express, Inc. (www.heartlandexpress.com) (HTLD) is pleased to announce that Chairman and CEO Michael Gerdin will ring the Closing Bell at the Nasdaq MarketSite in Times Square on Tuesday, November 10. The ceremony will recognize the 40th listing anniversary on the Nasdaq Stock Market and the 48th anniversary as a premier truckload transportation company. Joining Mr. Gerdin on stage will be more than 50 employees including professional truck drivers, founding family members, company leaders, long-term employees, and members of the board of directors. Mike Gerdin, CEO stated, "It is with great pride that we recognize this hon

    $HTLD
  • New Data Show Twice-Yearly Lenacapavir Achieved Nearly Twice the One-Year Persistence of Daily Oral F/TDF in HIV Prevention
    PR·

    New Data Show Twice-Yearly Lenacapavir Achieved Nearly Twice the One-Year Persistence of Daily Oral F/TDF in HIV Prevention

    – Zero HIV Acquisitions Occurred Among Participants Receiving Twice-Yearly Lenacapavir During the 52-Week Study Period – – PURPOSE 5 Study Findings Highlight the Potential of Long-Acting HIV Prevention Option to Address Persistence Challenges with Up to a Full Year of Protection After Second Dose – Gilead Sciences, Inc. (NASDAQ:GILD) today announced results from the PURPOSE 5 trial showing significantly higher persistence—defined as consistent and continuous on-time use—among people starting twice-yearly injectable lenacapavir for HIV prevention as pre-exposure prophylaxis (PrEP), compared with those starting daily oral emtricitabine/tenofovir disoproxil fumarate (F/TDF). The trial incl

    $GILD
  • New England Realty Associates LP Announces Fourth-Quarter Distribution on Class A Units and Depositary Receipts
    PR·

    New England Realty Associates LP Announces Fourth-Quarter Distribution on Class A Units and Depositary Receipts

    On December 31, 2026, New England Realty Associates Limited Partnership (NYSE:NEN) will make its quarterly distribution to its Class A Limited Partners and holders of Depositary Receipts of record as of December 16, 2026. The quarterly distribution per Class A Limited Partnership Unit will be $12.00 per Unit. The quarterly distribution per Depositary Receipt will be $0.40. Each Depositary Receipt represents a beneficial ownership of one-thirtieth of a Class A Partnership Unit. Depositary Receipts are listed on The NYSE MKT under the trading symbol "NEN". View original content:https://www.prnewswire.com/news-releases/new-england-realty-associate

    $NEN
  • Lifeway® Kefir Commercial Makes Chicagoland Television Debut Sunday, November 8, With New Muscle Mates™ Social Media Campaign to Follow
    PR·

    Lifeway® Kefir Commercial Makes Chicagoland Television Debut Sunday, November 8, With New Muscle Mates™ Social Media Campaign to Follow

    Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products, is bringing its partnership with Chicago football stars Colston Loveland and D'Andre Swift to a bigger stage. On Sunday, November 8, Lifeway's humorous kefir commercial featuring the two athletes will make its Chicagoland television debut, expanding the reach of a fan-favorite campaign that first launched exclusively on social media. The broadcast debut will be followed by an all-new, social-exclusive campaign featuring the players promoting Lifeway

    $LWAY
  • Northern Trust Pension Universe Data: Canadian Pension Plans Navigate Challenging Markets in Q3
    PR·

    Northern Trust Pension Universe Data: Canadian Pension Plans Navigate Challenging Markets in Q3

    Canadian pension plan returns fell in the third quarter, mostly a result of rising bond yields, with the median pension plan returning -1.5% for the quarter ending September 30 and 4.4% year-to-date, according to the Northern Trust Canada Universe. Third-quarter financial markets were shaped by the return of energy-driven inflation and a sharp rise in global interest rates. Middle East tensions returned to the foreground, pushing Brent crude oil above $100 per barrel and renewing concerns around inflation and energy supply. The rise in oil occurred against a backdrop of resilient economic activity and generally constructive corporate earnings. After holding rates in July, the U.S. Federal

    $NTRS
  • Perspective Therapeutics Presents Promising [212Pb]Lapemelanotide Zapixetar (VMT01) Monotherapy Data from a Phase 1/2a Study in Heavily Pretreated Advanced Melanoma Patients at SITC 2026
    PR·

    Perspective Therapeutics Presents Promising [212Pb]Lapemelanotide Zapixetar (VMT01) Monotherapy Data from a Phase 1/2a Study in Heavily Pretreated Advanced Melanoma Patients at SITC 2026

    Meaningful antitumor activity observed at the 3.0 mCi monotherapy dose with 75% disease control rate and durable disease stabilization; one of two confirmed responders remains on study ~40 weeks after the first treatmentNo dose-limiting toxicities, treatment-related serious adverse events, or discontinuations due to adverse events were reported across 20 patients in three monotherapy dose cohorts as of the data cut-off Continued evaluation and dose optimization of lapemelanotide to inform future clinical development

    $CATX
  • Immunocore presents promising data from Phase 1/2 trial cohort evaluating brenetafusp plus KIMMTRAK® (tebentafusp-tebn) in metastatic uveal melanoma
    PR·

    Immunocore presents promising data from Phase 1/2 trial cohort evaluating brenetafusp plus KIMMTRAK® (tebentafusp-tebn) in metastatic uveal melanoma

    In 17 first-line patients treated with the combination, the estimated two-year overall survival (OS) rate was 70% - Median OS was not reached at a median follow-up of 29 months and 10 patients remained on study Majority of patients (64%) with an OS over 2 years received only the combination The combination achieved a 29% overall response rate with a median duration of response of 24 months and a 71% disease control rate First data showing clinical activity and manageable safety profile with a combination of two T cell engagers in a solid tumor The Company is planning a Phase 2/3 randomized trial evaluating the combination in unresectable or metastatic uveal melanoma (OXFORDSHIRE, Engla

    $IMCR
  • Endava plc Investors Have Until November 30th to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role
    PR·

    Endava plc Investors Have Until November 30th to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role

    Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Endava (DAVA) To Contact Him Directly To Discuss Their Options If you purchased or acquired Endava securities between September 4, 2025 and September 21, 2026 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.

    $DAVA
  • European Commission approves AkzoNobel and Axalta merger of equals
    PR·

    European Commission approves AkzoNobel and Axalta merger of equals

    Akzo Nobel N.V. (AKZA; AKZOY) ("AkzoNobel") and Axalta Coating Systems Ltd. (NYSE:AXTA) ("Axalta") today received conditional approval from the European Commission for their proposed all-stock merger of equals, which will create a premier global coatings company. The transaction is expected to close in early 2027 subject to pending regulatory approvals. Following constructive discussions with the European Commission, AkzoNobel and Axalta have agreed to a targeted remedy involving the divestment of AkzoNobel’s European vehicle refinish business. The commitments offered fully address the preliminary competition concerns identifi

    $AXTA
  • Contracted Capacity, Containers on the Water: AZIO AI Moves Atlas One Into Its Equipment Phase
    PR·

    Contracted Capacity, Containers on the Water: AZIO AI Moves Atlas One Into Its Equipment Phase

    Project Atlas One is moving from plans into equipment. AZIO AI Holdings, Inc. (NASDAQ:AZIO) has containers on the water, equipment coming in one step at a time and a phased build coordinated with Texas site partner Texoil Ventures LLC, alongside its signed 10 MW Power Champion contract. Contracted today: Power Champion — 10 MW at $150 per kW per month, or $1.5 million per month at full delivery (about $90 million over 60 months). What is contracted todayToday, the only signed customer contract at Atlas One is AZIO's infrastructure hosting agreement with Power Champion: 10 MW at $150 per kW per month, or $1.5 million per month at full delivery an

    $AZIO
  • West Virginia American Water Advances Central Grove Project as Part of Broader Water System Upgrades
    PR·

    West Virginia American Water Advances Central Grove Project as Part of Broader Water System Upgrades

    West Virginia American Water is moving forward with additional upgrades to Jefferson County's water infrastructure with work to prepare the future site of the Central Grove Water Treatment Plant. The project is located near the intersection of Goldenrod Drive and Marie Drive. Initial work includes selective tree clearing, grading, decorative fencing, landscaping improvements, and well evaluation. The new water treatment plant will become part of the larger water system serving the area and represents an important step toward connecting the Mountain and Walnut Grove water systems. The Walnut Grove system already operates as an interconnected ne

    $AWK
  • Superior Group of Companies Declares Regular Quarterly Cash Dividend
    PR·

    Superior Group of Companies Declares Regular Quarterly Cash Dividend

    The Board of Directors of Superior Group of Companies, Inc. (NASDAQ:SGC) today announced that it has declared a quarterly dividend of $0.14 per share, payable November 25, 2026, to shareholders of record as of November 16, 2026. About Superior Group of Companies, Inc. (SGC):Established in 1920, Superior Group of Companies is comprised of three attractive business segments each serving large, fragmented and growing addressable markets. Across Healthcare Apparel, Branded Products and Contact Centers, each segment enables businesses to create extraordinary brand engagement experiences for their customers and employees. SGC’s commitment

    $SGC
  • Hudbay Files Technical Report for its Snow Lake Operations in Manitoba
    PR·

    Hudbay Files Technical Report for its Snow Lake Operations in Manitoba

    Hudbay Minerals Inc. ("Hudbay" or the "Company") (TSX, (TSX, NYSE:HBM) today announced that, further to the Company’s news release dated September 28, 2026, the Company has filed a National Instrument 43-101 technical report for its Snow Lake operations in Manitoba (the "2026 Technical Report"). Hudbay’s 100% owned Snow Lake operations in Manitoba include the Lalor gold-copper-zinc mine, the New Britannia gold mill, the Stall base metals concentrator, the 1901 zinc-gold deposit, several satellite deposits and the former producing New Britannia gold mine currently on care and maintenance. As disclosed in the September 28, 2026 news release, the h

    $HBM
  • Chemed Corporation Declares Quarterly Dividend of 70 Cents
    PR·

    Chemed Corporation Declares Quarterly Dividend of 70 Cents

    Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 70-cents per share on the Company’s capital stock, payable on December 4, 2026, to shareholders of record as of November 16, 2026. This is equal to the dividend paid in September 2026. This represents the 222nd consecutive quarterly dividend paid by Chemed in its 55 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life

    $CHE